Rockwell Medical Technologies (RIMT) Triferic Sales Not Material Enough To Even Disclose, Brean Capital Notes

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/22/2026

1. META
2. TSLA
3. IBM
4. TXN
5. MRNA
6. SAP
7. CSX
8. LRCX
9. MRK
10. LVS

Go back to Rockwell Medical Technologies (RIMT) Triferic Sales Not Material Enough To Even Disclose, Brean Capital Notes

Rockwell Medical (RMTI) Signs Triferic Supply Contract with Top Provider, Oppenheimer Notes

November 10, 2015 7:42 AM EST

Oppenheimer analyst Ling Wang reiterated an Outperform rating and $26 price target on Rockwell Medical Technologies (NASDAQ: RMTI) following the company Q3 updated. The analyst notes the company singed a signed a supply contract with one of the top four dialysis providers for Triferic, although... More

Rockwell Medical Technologies (RMTI) Misses Q3 EPS by 3c

November 9, 2015 4:58 PM EST

Rockwell Medical Technologies (NASDAQ: RMTI) reported Q3 EPS of ($0.05), $0.03 worse than the analyst estimate of ($0.02). Revenue for the quarter came in at $14.4 million versus the consensus estimate of $14.93 million.

For earnings history and earnings-related data on Rockwell Medical Technologies (RMTI) click here.

... More